相关实验视频
Updated: Jul 23, 2025

06:41
Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
Published on: May 19, 2023
1.9K
对血液造血干细胞衰老的原因,后果和纠正的新见解
Els Mansell1, Dawn S Lin2, Stephen J Loughran3
1Erasmus MC Hematology, Rotterdam, The Netherlands; Division of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden.
Experimental hematology
|July 11, 2023
概括
造血干细胞 (HSCs) 的衰老导致功能衰退和疾病倾向. 这篇评论探讨了炎症和HSC衰老的利基因素以及潜在的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 干细胞生物学 干细胞生物学
- 衰老研究研究 衰老研究
背景情况:
- 衰老的造血干细胞 (HSC) 呈现出血统偏差,功能减弱和改变的分子形状.
- 关键的分子变化包括代谢失调,炎症增加和老年HSCs的DNA修复受损.
- 高血小细胞的细胞衰老有助于与年龄相关的血液学疾病,如贫血,免疫损害和癌症.
研究的目的:
- 探索与年龄相关的HSC健康状况下降的生物学基础.
- 讨论炎症和干细胞利基在HSC衰老中的作用.
- 对与年龄相关的造血功能障碍的治疗策略进行推测.
主要方法:
- 审查来自领先实验室的最新见解.
- 专注于干细胞衰老的炎症和利基驱动机制.
- 讨论与年龄相关的HSC衰退的潜在干预措施.
主要成果:
- 陈旧的HSCs表现出明显的分子和功能缺陷.
- 无论是内在的细胞因素还是外在的利基相互作用,都会导致HSC衰老.
- 炎症信号和利基变化是HSC衰老的关键因素.
结论:
- 与年龄相关的HSC功能下降是多因素的,涉及炎症和利基变化.
- 了解这些机制可能会揭示治疗点,以改善老年人的造血健康.
- 对高血小板衰老的进一步研究可能会导致预防或逆转与年龄相关的造血性疾病的策略.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K

